Aspen Australia

Aspen Australia

Aspen Australia commenced operations in May 2001 with a portfolio of products generating sales of around $10 million. After the acquisition of the Sigma pharmaceutical business in February 2011, current annualised sales are close to $900 million in Australia and New Zealand. Aspen Australia is also responsible for a growing business in a dozen countries in Asia accounting for about $83 million in in-market sales.

Besides marketing and distributing products owned by the Aspen Group, we also license in products from other companies, and are focused on meeting the needs of our licensors.

Back to list   Visit website